More than 85% of UMs are initiated by a mutation in G protein subunit alpha q (GNAQ) or alpha 11 (GNA11),[4] among which 95% are a Q209P/L single‐site mutation,[5] which is a pivotal carcinogenic factor in the pathogenesis and progression of UM. The gene discussed is GNAQ; the disease is ulnar-mammary syndrome.